Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Harvard Business School
Baxter
Medtronic
Johnson and Johnson

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,635,045

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,635,045 protect, and when does it expire?

Patent 6,635,045 protects LIDOSITE TOPICAL SYSTEM KIT and is included in one NDA.

This patent has eight patent family members in seven countries.

This patent has expired prematurely due to non-payment of maintenance fees. See details below.

Summary for Patent: 6,635,045
Title: Electrodes and method for manufacturing electrodes for electrically assisted drug delivery
Abstract:Provided is a method for loading electrode-corroding ingredients into an un-loaded donor gel reservoir of an electrode for an electrically assisted drug delivery system. The method provides that a salt, such as sodium chloride or an organic salt, is provided in the un-loaded donor gel reservoir, contrary to convention. Related electrically assisted drug delivery electrode assemblies also are provided.
Inventor(s): Keusch; Preston (Hazlet, NJ), Jain; Uday K. (Mahway, NJ), Reddy; Vilambi Nrk (Tamil/Nadu, IN), Eliash; Bruce M. (Franklin Lakes, NJ), Carey; Kevin John (North Plainfield, NJ), Falevich; Vitaly (Ozone Park, NJ)
Assignee: Vyteris, Inc. (Fair Lawn, NJ)
Application Number:09/897,698
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Delivery; Process;

Drugs Protected by US Patent 6,635,045

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 DISCN No No   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,635,045

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 369891   Start Trial
Australia 7310401   Start Trial
Canada 2413624   Start Trial
Germany 60129965   Start Trial
European Patent Office 1294439   Start Trial
Japan 2004501727   Start Trial
Japan 4024673   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Merck
Moodys
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.